Front Row Advisors’s Fresenius Medical Care FMS Stock Holding History

Front Row Advisors’s Portfolio FMS Stock Details FMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-324	Closed	-$8K	–	922
2022 Q2	$8K	Sell	324 -7	-2%	-$209	﹤0.01%	551
2022 Q1	$11K	Buy	331 +114	+53%	+$3.75K	﹤0.01%	533
2021 Q4	$7K	Sell	217 -128	-37%	-$4.21K	﹤0.01%	660
2021 Q3	$12K	Hold	345	–	–	0.01%	514
2021 Q2	$14K	Hold	345	–	–	0.01%	489
2021 Q1	$13K	Hold	345	–	–	0.01%	494
2020 Q4	$14K	Hold	345	–	–	0.01%	450
2020 Q3	$15K	Sell	345 -42	-11%	-$1.81K	0.01%	422
2020 Q2	$17K	Buy	387 +38	+11%	+$1.5K	0.01%	369
2020 Q1	$14K	Sell	349 -2	-0.6%	-$74	0.01%	396
2019 Q4	$13K	Buy	351 +55	+19%	+$1.95K	0.01%	405
2019 Q3	$10K	Buy	296 +48	+19%	+$1.7K	0.01%	441
2019 Q2	$10K	Sell	248 -6	-2%	-$238	0.01%	433
2019 Q1	$10K	Buy	254 +91	+56%	+$3.39K	0.01%	444
2018 Q4	$5K	Sell	163 -46	-22%	-$1.86K	﹤0.01%	532
2018 Q3	$8	Buy	209 +74	+55%	+$3.7K	0.01%	456
2018 Q2	$7	Buy	+135	New	+$6.84K	﹤0.01%	513

Other funds holding FMS

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Front Row Advisors's FMS Position: Q3 2022 in Review

Front Row Advisors sold out of Fresenius Medical Care (FMS) in Q3 2022, closing a stake of 324 shares — an estimated $8K sold.

Front Row Advisors first reported a position in FMS in Q2 2018 and held it in 17 quarters. The position peaked at $17K in Q2 2020. 141 funds tracked by Wall St. Rank hold FMS as of Q3 2022.

Front Row Advisors reported no remaining Fresenius Medical Care position as of Q3 2022 after selling out during the quarter.
Front Row Advisors sold 324 Fresenius Medical Care shares in Q3 2022, an estimated $8K.
Front Row Advisors first reported a position in Fresenius Medical Care in Q2 2018 and held it in 17 quarters.
Front Row Advisors's Fresenius Medical Care position peaked at $17K in Q2 2020.
141 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2022.

Based on Front Row Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.